CIK: 0001377635
Total reported value
$267.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VWO | Vanguard Ftse Emerging Marke | ETF-Emerging Markets | 81.83% | — | -7.68% | |
| 2 | ✓ | Anacor Pharmaceuticals INC | Stock-Other | 2.55% | — | — | |
| 3 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 2.29% | — | — | |
| 4 | INCY | Incyte CORP | Stock-Healthcare | 2.21% | — | — | |
| 5 | ✓ | Bellicum Pharmaceuticals INC | Stock-Other | 1.98% | — | — | |
| 6 | SGENEUR | Seagen INC | Stock-Other | 1.97% | — | — | |
| 7 | GHDX | Genomic Health INC | Stock-Other | 1.86% | — | — | |
| 8 | ✓ | Synageva Biopharma CORP | Stock-Other | 1.82% | — | — | |
| 9 | ACAD | Acadia Pharmaceuticals INC | Stock-Healthcare | 1.81% | — | — | |
| 10 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 1.68% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | VWO | Vanguard Ftse Emerging Marke | -18.2% | -7.68% | Trim |
| 2 | ✓ | Anacor Pharmaceuticals INC | — | NEW | New buy |
| 3 | BMRN | Biomarin Pharmaceutical INC | — | NEW | New buy |
| 4 | INCY | Incyte CORP | — | NEW | New buy |
| 5 | ✓ | Bellicum Pharmaceuticals INC | — | NEW | New buy |
| 6 | SGENEUR | Seagen INC | — | NEW | New buy |
| 7 | GHDX | Genomic Health INC | — | NEW | New buy |
| 8 | ✓ | Synageva Biopharma CORP | — | NEW | New buy |
| 9 | ACAD | Acadia Pharmaceuticals INC | — | NEW | New buy |
| 10 | BCRX | Biocryst Pharmaceuticals INC | — | NEW | New buy |